Answers are grounded in this paper and cite their sources.
Abstract Male breast cancer (MBC) is a relatively rare and inadequately researched disease, and its cellular and molecular traits remain obscure. In this study, we conducted single-cell sequencing (N=20) and spatial transcriptomics (N=14) on 34 fresh tissue samples from 27 MBC patients. We identified six major cancer cell subtypes that are associated with the development and progression of MBC. Specifically, cancer cells exhibiting neuroendocrine-like properties facilitate immune evasion, tumor angiogenesis, epithelial-to-mesenchymal transition, cell proliferation, tumor invasion, and metastasis. They do so by secreting neuro-related factors and engaging in regulating neuro-related signaling pathways, synergistically interacting with T cells, macrophages, and fibroblasts within the tumor microenvironment. Additionally, we found that mutations or copy number variations amplifications of the UTY gene on the Y chromosome and/or its high transcript expression are closely associated with adverse clinical outcomes in male cancer patients, including MBC patients. In conclusion, our study provides important data support for a deeper understanding of the molecular characteristics and tumor microenvironment of MBC, and offers important clues for developing improved therapeutic strategies to improve the prognosis of MBC patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: